CL
SP100NYSEColgate-Palmolive Company
Consumer Defensive · Household & Personal Products · United States
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
www.colgatepalmolive.com ↗Shares trade at a premium 36.9× trailing earnings, easing to 23.5× on forward estimates. Profitability shows a net margin of 10.0% and return on equity of 363.6%. Leverage is modest at 1.3× net debt/EBITDA. Revenue grew 8.4% year-on-year. It yields 2.2% in dividends. The mean analyst target of USD95.85 sits 0.8% above the current price (Buy, 20 analysts).
business model
Colgate-Palmolive is a global consumer-products company that manufactures and markets oral care, personal care, home care, and pet nutrition products. It sells branded, everyday consumables through retail, e-commerce, and distribution channels worldwide, relying on brand strength and broad geographic reach, especially in emerging markets.
revenue segments
Revenue comes from Oral Care (toothpaste, toothbrushes, mouthwash under the Colgate brand), Personal Care (soaps, body wash, deodorants such as Palmolive, Softsoap, Speed Stick), Home Care (dish and cleaning products like Ajax, Fabuloso), and Pet Nutrition through Hill's Science Diet and Prescription Diet.
key dependencies
The company depends on the strength of its flagship brands (particularly its leading global toothpaste share), pricing power to offset raw-material and packaging cost inflation, distribution reach in developing markets, and advertising to sustain brand loyalty and market share.
competitors
Competitors include Procter & Gamble (Crest, Oral-B, and personal care), Unilever, Church & Dwight, Henkel, and Reckitt in consumer products, plus Mars, Nestlé Purina, and others in pet nutrition.
moat
Colgate's moat comes from powerful global brands, leading market share in toothpaste (a habitual, low-price repeat purchase), extensive distribution in emerging markets, and scale in manufacturing and marketing that supports consistent shelf presence.
risks
Risks include commodity and currency headwinds (with heavy emerging-market exposure), competition and private-label pressure, slowing category volume growth, retailer bargaining power, and dependence on Hill's for pet-nutrition growth.
Financials & metrics
as of 28 Aug 2026Price is closer to the high end of its range. Green = nearer the yearly low, red = nearer the high — a position indicator, not a buy/sell signal.
Tap any metric for an explanation.● provider● computedN/A not available from source
Valuation history is being recorded
We snapshot P/E and price targets daily. This chart fills in over the coming days.
Full financial statements
Income statement
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | $20.38B | $20.10B | $19.46B | $17.97B | — |
| Cost of revenue | $8.13B | $7.94B | $8.13B | $7.72B | — |
| Gross profit | $12.25B | $12.16B | $11.33B | $10.25B | — |
| Operating expense | $8.02B | $7.83B | $7.24B | $6.63B | — |
| Operating income | $4.23B | $4.33B | $4.08B | $3.62B | — |
| Interest expense | $267.00M | $292.00M | $287.00M | $167.00M | — |
| Pretax income | $3.06B | $3.96B | $3.39B | $2.66B | — |
| Tax provision | $798.00M | $907.00M | $937.00M | $693.00M | — |
| Net income | $2.13B | $2.89B | $2.30B | $1.78B | — |
| EBITDA | $3.96B | $4.85B | $4.25B | $3.37B | — |
| Diluted EPS | $2.63 | $3.51 | $2.77 | $2.13 | — |
Balance sheet
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $16.33B | $16.05B | $16.39B | $15.73B | — |
| Current assets | $5.71B | $5.32B | $5.28B | $5.11B | — |
| Cash & equivalents | $1.29B | $1.10B | $966.00M | $775.00M | — |
| Inventory | $2.03B | $1.99B | $1.93B | $2.07B | — |
| Total liabilities | $15.96B | $15.50B | $15.44B | $14.93B | — |
| Current liabilities | $6.85B | $5.76B | $4.74B | $4.00B | — |
| Total debt | $8.55B | $8.51B | $9.06B | $9.27B | — |
| Long-term debt | $6.87B | $7.29B | $8.22B | $8.74B | — |
| Shareholders' equity | $54.00M | $212.00M | $609.00M | $401.00M | — |
| Retained earnings | $26.59B | $26.14B | $25.29B | $24.57B | — |
| Working capital | -$1.14B | -$442.00M | $538.00M | $1.11B | — |
Cash flow
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $4.20B | $4.11B | $3.75B | $2.56B | — |
| Investing cash flow | -$817.00M | -$534.00M | -$742.00M | -$1.60B | — |
| Financing cash flow | -$3.26B | -$3.39B | -$2.79B | -$952.00M | — |
| Capital expenditure | -$564.00M | -$561.00M | -$705.00M | -$696.00M | — |
| Free cash flow | $3.63B | $3.55B | $3.04B | $1.86B | — |
| Dividends paid | -$1.82B | -$1.79B | -$1.75B | -$1.69B | — |
| Share buybacks | -$1.21B | -$1.74B | -$1.13B | -$1.31B | — |
| End cash position | $1.29B | $1.10B | $966.00M | $775.00M | — |
Reported figures from public filings via Yahoo Finance. Line coverage varies by company. Not investment advice.
Dividends
Analyst assessment
as of 28 Aug 2026Aggregate consensus only. Named per-analyst targets require a premium source and are not shown; the data model is ready to hold them if one is added.
Technicals
as of 27 Aug 2026News
Sector peers
Notes & alerts
Sign in to keep a private research note and set price alerts for CL.